Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
41,531,418
-
Share change
-
-3,829,096
-
Total reported value
-
$25,580,570
-
Put/Call ratio
-
18%
-
Price per share
-
$0.62
-
Number of holders
-
42
-
Value change
-
-$3,278,836
-
Number of buys
-
12
-
Number of sells
-
25
Institutional Holders of HOOKIPA PHARMA - COM (HOOK) as of Q3 2023
As of 30 Sep 2023,
HOOKIPA PHARMA - COM (HOOK) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,531,418 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, Artal Group S.A., Knoll Capital Management, LLC, EcoR1 Capital, LLC, ARMISTICE CAPITAL, LLC, FMR LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, Redmile Group, LLC, and MORGAN STANLEY.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.